Literature DB >> 29360467

Parkinson's disease from the gut.

Rodger A Liddle1.   

Abstract

Parkinson's disease (PD) is a debilitating neurodegenerative condition associated with tremor, rigidity, dementia, and gastrointestinal symptoms such as constipation, nausea and vomiting. The pathological hallmarks of PD are Lewy bodies and neurites in the brain and peripheral nerves. The major constituent of Lewy bodies is the neuronal protein α-synuclein. Misfolding of α-synuclein confers prion-like properties enabling its spread from cell to cell. Misfolded α-synuclein also serves as a template and induces misfolding of endogenous α-synuclein in recipient cells leading to the formation of oligomers that progress to fibrils and eventually Lewy bodies. Accumulating evidence suggests that PD may arise in the gut. Clinically, gastrointestinal symptoms often appear in patients before other neurological signs and aggregates of α-synuclein have been found in enteric nerves of PD patients. Importantly, patients undergoing vagotomy have a reduced risk of developing PD. Experimentally, abnormal forms of α-synuclein appear in enteric nerves before they appear in the brain and injection of abnormal α-synuclein into the wall of the intestine spreads to the vagus nerve. Ingested toxins and alterations in gut microbiota can induce α-synuclein aggregation and PD, however, it is not known how PD starts. Recently, it has been shown that sensory cells of the gut known as enteroendocrine cells (EECs) contain α-synuclein and synapse with enteric nerves, thus providing a connection from the gut to the brain. It is possible that abnormal α-synuclein first develops in EECs and spreads to the nervous system. Published by Elsevier B.V.

Entities:  

Keywords:  Alpha-synuclein; Enteroendocrine cell; Gastrointestinal tract; Lewy body; Parkinson’s disease; Prion

Mesh:

Substances:

Year:  2018        PMID: 29360467      PMCID: PMC6003841          DOI: 10.1016/j.brainres.2018.01.010

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  81 in total

1.  A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease.

Authors:  H Pouclet; T Lebouvier; E Coron; S B Des Varannes; M Neunlist; P Derkinderen
Journal:  Neurogastroenterol Motil       Date:  2012-01-31       Impact factor: 3.598

2.  A not entirely benign procedure: progression of Parkinson's disease.

Authors:  Kelly Del Tredici; Heiko Braak
Journal:  Acta Neuropathol       Date:  2008-04       Impact factor: 17.088

3.  Is Parkinson's disease a prion disorder?

Authors:  C Warren Olanow; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

Review 4.  Parkinson's disease: the dual hit theory revisited.

Authors:  Christopher H Hawkes; Kelly Del Tredici; Heiko Braak
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

5.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

6.  Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Ece Mutlu; Hemraj B Dodiya; Delia Daian; Jean A Jaglin; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2011-07-15       Impact factor: 10.338

Review 7.  Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.

Authors:  S A Schneider; M Boettner; A Alexoudi; D Zorenkov; G Deuschl; T Wedel
Journal:  Eur J Neurol       Date:  2015-06-23       Impact factor: 6.089

Review 8.  Structural insights on physiological functions and pathological effects of alpha-synuclein.

Authors:  Marco Bisaglia; Stefano Mammi; Luigi Bubacco
Journal:  FASEB J       Date:  2008-10-23       Impact factor: 5.191

9.  Caudo-rostral brain spreading of α-synuclein through vagal connections.

Authors:  Ayse Ulusoy; Raffaella Rusconi; Blanca I Pérez-Revuelta; Ruth E Musgrove; Michael Helwig; Bettina Winzen-Reichert; Donato A Di Monte
Journal:  EMBO Mol Med       Date:  2013-05-23       Impact factor: 12.137

10.  Exosomal cell-to-cell transmission of alpha synuclein oligomers.

Authors:  Karin M Danzer; Lisa R Kranich; Wolfgang P Ruf; Ozge Cagsal-Getkin; Ashley R Winslow; Liya Zhu; Charles R Vanderburg; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2012-08-24       Impact factor: 14.195

View more
  44 in total

1.  Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease.

Authors:  Hirokazu Doi; Ryuji Sakakibara; Masayuki Masuda; Fuyuki Tateno; Yosuke Aiba; Masahiko Kishi; Tomonori Yamanishi; Tatsuya Yamamoto; Katsuyoshi Matsuoka
Journal:  Clin Auton Res       Date:  2019-02-11       Impact factor: 4.435

2.  Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.

Authors:  Cecilia Bove; Laura Anselmi; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-05-01       Impact factor: 4.052

3.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

Review 4.  Early life interaction between the microbiota and the enteric nervous system.

Authors:  Jaime P P Foong; Lin Y Hung; Sabrina Poon; Tor C Savidge; Joel C Bornstein
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-09       Impact factor: 4.052

Review 5.  Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.

Authors:  Mohamed El-Gamal; Mohamed Salama; Lyndsey E Collins-Praino; Irina Baetu; Ahmed M Fathalla; Amira M Soliman; Wael Mohamed; Ahmed A Moustafa
Journal:  Neurotox Res       Date:  2021-03-25       Impact factor: 3.911

Review 6.  Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.

Authors:  Richard A Manfready; Christopher B Forsyth; Robin M Voigt; Deborah A Hall; Christopher G Goetz; Ali Keshavarzian
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-28       Impact factor: 5.081

Review 7.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

8.  Association between heart rate variability and striatal dopamine depletion in Parkinson's disease.

Authors:  Tomomichi Kitagawa; Tadashi Umehara; Hisayoshi Oka; Tomotaka Shiraishi; Takeo Sato; Hiroki Takatsu; Atsuo Nakahara; Hiromasa Matsuno; Keiko Bono; Shusaku Omoto; Hidetomo Murakami; Renpei Sengoku; Yasuyuki Iguchi
Journal:  J Neural Transm (Vienna)       Date:  2021-09-24       Impact factor: 3.575

Review 9.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Curr Treat Options Neurol       Date:  2018-10-25       Impact factor: 3.598

10.  Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.

Authors:  Zachary A Sorrentino; Ethan Hass; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.